Agilent Technologies, Inc. (BIT:1A)
Italy · Delayed Price · Currency is EUR 109.90
+0.84 (0.77%)
At close: Sep 5, 2025
Revenue by Product
Fiscal year is November - October.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Oct '24 Oct 31, 2024 | Oct '23 Oct 31, 2023 | Oct '22 Oct 31, 2022 | Oct '21 Oct 31, 2021 | Oct '20 Oct 31, 2020 | 2012 - 2019 |
Life Sciences & Diagnostics Markets | 2.47B | Log In | Log In | Log In | Log In | Upgrade |
Agilent CrossLab Revenue (Post-FY2024 Reporting) | 2.75B | Log In | Log In | Log In | Log In | Upgrade |
Applied Markets | 1.30B | Log In | Log In | Log In | Log In | Upgrade |
Life Sciences & Applied Markets | 3.22B | Log In | Log In | Log In | Log In | Upgrade |
Life Sciences & Applied Markets Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Diagnostics & Genomics | 1.65B | Log In | Log In | Log In | Log In | Upgrade |
Diagnostics & Genomics Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Agilent CrossLab Revenue (Pre-FY2025 Reporting) | 1.64B | Log In | Log In | Log In | Log In | Upgrade |
Agilent CrossLab Revenue (Pre-FY2025 Reporting) Growth | - | Log In | Log In | Log In | Log In | Upgrade |
EBIT by Product
Fiscal year is November - October.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Oct '24 Oct 31, 2024 | Oct '23 Oct 31, 2023 | Oct '22 Oct 31, 2022 | Oct '21 Oct 31, 2021 | Oct '20 Oct 31, 2020 | 2012 - 2019 |
Other | -177.00M | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Life Sciences & Diagnostics Markets Income from Operations | 484.00M | Log In | Log In | Log In | Log In | Upgrade |
Agilent CrossLab Income from Operations (Post-FY2024 Reporting) | 925.00M | Log In | Log In | Log In | Log In | Upgrade |
Applied Markets Income from Operations | 312.00M | Log In | Log In | Log In | Log In | Upgrade |
Other | -177.00M | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Life Sciences & Applied Markets Income from Operations | 877.00M | Log In | Log In | Log In | Log In | Upgrade |
Life Sciences & Applied Markets Income from Operations Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Diagnostics & Genomics Income from Operations | 320.00M | Log In | Log In | Log In | Log In | Upgrade |
Diagnostics & Genomics Income from Operations Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Agilent CrossLab Income from Operations (Pre-FY2025 Reporting) | 524.00M | Log In | Log In | Log In | Log In | Upgrade |
Agilent CrossLab Income from Operations (Pre-FY2025 Reporting) Growth | - | Log In | Log In | Log In | Log In | Upgrade |